NYSE:CVS - CVS Health Stock Price, Forecast & News

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Thursday, October 3rd. Shareholders of record on Thursday, October 24th will be given a dividend of $0.50 per share on Monday, November 4th. This represents a $2.00 annualized dividend and a yield of 2.72%. The ex-dividend date is Wednesday, October 23rd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) released its quarterly earnings results on Wednesday, November, 6th. The pharmacy operator reported $1.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.77 by $0.07. The pharmacy operator earned $64.81 billion during the quarter, compared to analysts' expectations of $62.99 billion. CVS Health had a return on equity of 15.45% and a net margin of 1.83%. CVS Health's revenue for the quarter was up 36.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.73 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for CVS Health.

CVS Health updated its FY19 earnings guidance on Wednesday, November, 6th. The company provided EPS guidance of $6.97-7.05 for the period, compared to the Thomson Reuters consensus estimate of $6.98.

24 analysts have issued 12-month price targets for CVS Health's stock. Their forecasts range from $61.00 to $91.00. On average, they anticipate CVS Health's stock price to reach $77.14 in the next year. This suggests a possible upside of 4.8% from the stock's current price. View Analyst Price Targets for CVS Health.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 6 hold ratings, 17 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News stories about CVS stock have been trending positive on Friday, according to InfoTrie. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. CVS Health earned a media sentiment score of 2.2 on InfoTrie's scale. They also assigned media stories about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Petmed Express (PETS), Rite Aid (RAD), 111 (YI), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), NVIDIA (NVDA), Cisco Systems (CSCO), Alibaba Group (BABA), Home Depot (HD), Johnson & Johnson (JNJ), Verizon Communications (VZ), Intel (INTC) and Bank of America (BAC).

CVS Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include State Street Corp (4.66%), Parnassus Investments CA (0.64%), Boston Partners (0.63%), Veritas Asset Management LLP (0.52%), Parametric Portfolio Associates LLC (0.42%) and Sumitomo Mitsui Trust Holdings Inc. (0.38%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Veritas Asset Management LLP, Focused Investors LLC, Boston Partners, Sumitomo Mitsui Trust Holdings Inc., Diamond Hill Capital Management Inc., Russell Investments Group Ltd., State Street Corp and State of New Jersey Common Pension Fund D. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Artemis Investment Management LLP, Haverford Trust Co., California Public Employees Retirement System, Polaris Greystone Financial Group LLC, Atalanta Sosnoff Capital LLC, Parametric Portfolio Associates LLC and Point72 Asset Management L.P.. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $73.59.

CVS Health has a market capitalization of $95.74 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]